AORTECH INTERNATIONAL PLC
16 September 1999
DISTRIBUTION AGREEMENT WITH MEDOS OF GERMANY
AorTech International, ('AorTech') the Scottish based
manufacturer of cardiovascular devices, announces that it
has concluded a Distribution Agreement with MEDOS, a major
cardiovascular device company in Germany. The agreement is
for the sale of AorTech's established replacement heart
valve products i.e. the Ultracor Mechanical Valve, the
Tissue Heart Valve and the Mitral Repair System.
Eddie McDaid, AorTech's Managing Director commented:
'We are delighted to have concluded this Distribution
Agreement with MEDOS who, with their own cardiovascular
devices product range, have a significant market share in
Germany. Our core product range is presently marketed in
Germany through a restricted number of Open Heart Centres
and MEDOS, with their nationwide sales force, will be able
to sell our complementary products into the rest of the Open
Heart Centres in Germany. The German heart valve replacement
market represents approximately 26% of the European market
and is the single most important market in Europe and the
second most important in the world. This Agreement shows
continued acceptance of our product lines.'
Karl Heinz Hildinger, Managing Director of MEDOS, which has
over 15% of the German cardiopulmonary product market, in
sales terms, said:
'We are pleased to have concluded a Distribution Agreement
for AorTech's heart valve replacement products which will
complement our own cardiovascular device sales in Germany.
MEDOS recognises AorTech's products as a quality range of
heart valve replacements and anticipate significant sales
growth over the next two years.'
Enquiries:
AorTech International plc Tel: 01698 746699
Eddie McDaid, Managing Director
College Hill Tel: 0171 457 2020
Michael Padley
Copies of this statement will be available for a period of
14 days from the Company's registered office: Phoenix
Crescent, Strathclyde Business Park, Bellshill, Scotland ML4
3NU.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.